Resultats globals: 1 registres trobats en 0.02 segons.
Articles, 1 registres trobats
Articles 1 registres trobats  
1.
14 p, 1.5 MB Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients with Type 2 Diabetes : A Randomized Controlled Trial / Kumar, Ajay (Diabetes Care & Research Centre (Índia)) ; Franek, Edward (Polish Academy of Sciences) ; Wise, Jonathan (Tulane Medical School) ; Niemeyer, Marcus (Market Access and Public Affairs, Novo Nordisk Pharma (Alemanya)) ; Mersebach, Henriette (Clinical Development & Research-Diabetes & Novo Nordisk (Estats Units d'Amèrica)) ; Simó Canonge, Rafael (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Universitat Autònoma de Barcelona
The efficacy and safety of insulin degludec/insulin aspart (IDegAsp) once daily (OD) compared with insulin glargine U100 (IGlar) OD over 52 weeks in insulin-naïve adults with type 2 diabetes mellitus (T2DM) was investigated. [...]
2016 - 10.1371/journal.pone.0163350
PloS one, Vol. 11 (october 2016)  

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.